Breast Cancer Clinical Trials in Panjin, Liaoning
2 recruitingPanjin, Liaoning, China
Showing 1–2 of 2 trials
Recruiting
Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy
Breast Cancer
Shengjing Hospital1,000 enrolled12 locationsNCT04476485
Recruiting
Phase 4
Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
Breast Cancer
Shengjing Hospital110 enrolled7 locationsNCT04136782